Releases Details

MaxCyte, Inc.

("MaxCyte" or the "Company")

Increase to Block Listing,

Block Listing Return

and

Total Voting Rights

MaxCyte (LSE: MXCT, MXCS), the global cell-based medicines and life sciences company, announces that application has been made for admission to trading on AIM in respect of an additional block listing of 942,900 common stock of $0.01 each in the capital of the Company ("Common Stock") to become effective on 27 January 2021.

The Common Stock may be issued pursuant to the exercise of share options under the Company's Long-Term Incentive Plan (the "LTIP") and will, upon issue, rank pari passu in all respects with the Company's existing Common Stock. Following this increase, the total Block Listing will consist of 1,000,000 Common Stock.

AIM Block Admission Return

MaxCyte also makes the following update on its block listings, pursuant to AIM Rule 29 and Schedule Six of the AIM Rules for Companies.  

a. Name of company

MaxCyte, Inc.

b. Name of scheme(s)

MaxCyte Long Term Incentive Plan

c. Period of return:

From:  1 July 2020                                                           To:   21 January 2021

d. Number and class of securities not issued under scheme

319,263 ordinary shares of common stock of $0.01 each

e. Number of shares issued under scheme during period

262,163 ordinary shares of common stock of $0.01 each

f. Balance under the scheme not yet issued at the end of the period.

57,100 ordinary shares of common stock of $0.01 each

g. Number and class of share(s) (amount of stock / debt securities) originally listed and the date of admission; If additional block listing application have been made, under this scheme, since the original listing application please also state the number of shares and the date(s) of admission.

1,000,000 ordinary shares of common stock of $0.01 each on 5 May 2017

Please confirm your total issued share capital as at the end of this period.

(If you hold any shares in Treasury state the figure separately);

The total issued stock capital of the Company is 77,422,169 shares of Common Stock. Shareholders in the Company may use this figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the stock capital of the Company.

The number of unrestricted shares of Common Stock trading under the symbol 'MXCT' is 67,522,080 and the number of restricted shares of Common Stock trading under the symbol 'MXCS' is 9,900,089.  

Treasury shares (if applicable) ………Nil………….

h. Contact name and telephone number for queries;

Doug Doerfler, Chief Executive Officer

Ron Holtz, Chief Accounting Officer

+1 301 944 1660

Date     

21 January 2021